Atturos
Atturos uses proteomics technology to help clinicians and patients make more informed treatment decisions for prostate cancer.
- Stage Concept Only
- Industry Biotechnology
- Location Pilates Dublin . ie, Dublin, Ireland
- Currency EUR
- Founded January 2013
- Employees 2
- Website atturos.com
Company Summary
Atturos builds innovative biomarker-based diagnostic tests to support clinical decision making in prostate cancer. With its advanced protein biomarker discovery capability and MRM-based validation platform, Atturos has identified a panel of proteins predictive of extracapsular extension (ECE) in prostate cancer, which it is developing into a clinically validated test to ensure clinicians and patients make a more informed decision about treatment.
Team
-
Stephen Pennington - CSOProf
Founder
-
Dolores Cahill - CEOProf
Co-Founder
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.